The nation of Zimbabwe has declined a significant US health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' demand for sensitive information.
This move became public following a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesperson later clarified that the US was requesting health data for research and commercial gain while was unwilling to share the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for continued negotiations to find a agreement suitable to both sides so the country's critical HIV programme can continue.
Wider Background
This rejection follows a similar situation in Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the safety of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government agreements to boost openness and accountability.
Based on statements, Sixteen African countries have so far signed these new agreements, constituting more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership could have provided immense benefits for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding promise of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," he stated.
"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the end products would be available to our citizens should a new disease outbreak emerge."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures already set up via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage potential pandemics.
"This mechanism is designed to ensure that when a country provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," he added.
"We welcome ongoing discussions with our US partners on how subsequent co-operation might be arranged in a manner that honours the independence and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations should continue since much of the country's HIV programmes were funded by international support.
"In cases where specific concerns arise, including those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The situation emphasises the complex debate between accepting crucial foreign assistance and protecting a country's data in an ever more data-driven world.